RWE Clears Permits for Two Hydrogen-Ready Plants as Lingen Turbine Test Fires Up
Published on 11/07/2026 at 06:03 | Editorial boerse-global.de
RWE has secured construction approvals for two hydrogen-capable power stations while simultaneously launching full-scale testing of the turbine technology meant to equip them, giving investors a rare paired look at both the regulatory and engineering sides of its flexible-generation build-out.
The District Government of Cologne handed over the permits, with regional president Gregor Lange signing off on a gas-and-steam turbine plant at the Weisweiler site in Eschweiler and a gas engine facility at the Knapsack site in Hürth. Both installations are designed to step in when wind and solar output falls short of demand, shoring up supply security and grid stability — a role that defines their value to RWE's portfolio rather than bulk baseload output.
A 34-MW Proving Ground in Lingen
On the same day, RWE Generation SE and Kawasaki Heavy Industries began trial operation of a 34-megawatt gas turbine in Lingen, which RWE bills as Europe's largest fully hydrogen-capable facility of its kind. Over the coming months the partners will run the unit on natural gas and on blends rising to 100% hydrogen, covering a range of operating modes and load conditions.
The hydrogen is supplied by the adjacent electrolysers of the GET H2 Nukleus, produced using renewable power. The combustion technology was previously validated in smaller units; according to Nikolaus Valerius, head of RWE Generation, the Lingen turbine delivers up to ten times the output of the hydrogen turbines tested to date.
Should investors sell immediately? Or is it worth buying Rwe?
Why the Field Test Matters for the Investment Case
The trial's significance lies in whether hydrogen-capable plant technology translates into a dependable operating proposition — the question that ultimately underpins RWE's parallel power station projects. A convincing demonstration under real-world conditions would strengthen the case for rolling the concept out across further facilities; results that stay tied to Lingen's specific circumstances would carry less weight for the wider programme.
Setbacks uncovered during operation would temper expectations of a smooth build-out, making it critical to watch whether problems can be resolved within the trial or demand deeper modifications. Cautious investors may prefer to tie any confidence premium to verifiable milestones, while a more optimistic stance becomes defensible once RWE can point to both convincing operating experience and tangible construction progress.
Permits and Auctions Build the Commercial Backdrop
Those construction steps are already taking shape. On Tuesday RWE reported winning bids for projects in Voerde, Weisweiler and Werne totalling around 2,100 rMW, with the plants slated to provide capacity over 15 years. The company also said construction of the first plant should begin within a few weeks. Permits and the field test address different halves of the same investor question: the projects give the technology a concrete destination, while the Lingen trial could sharpen the view of how executable they are.
The Next Checkpoint
The next scheduled marker is 11 November 2026, when RWE has announced its interim report for the first three quarters of 2026 alongside an investor and analyst conference. That date offers the next opportunity to weigh business performance together with any commentary on project progress — and for a stronger investment thesis, technical advances and commercial prospects will need to line up.
Ad
Rwe Stock: New Analysis - 7 November
Fresh Rwe information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
